Galectin‐3 as a biomarker in breast neoplasms: Mechanisms and applications in patient care
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Galectin‐3 as a biomarker in breast neoplasms: Mechanisms and applications in patient care
Authors
Keywords
-
Journal
JOURNAL OF LEUKOCYTE BIOLOGY
Volume 112, Issue 5, Pages 1041-1052
Publisher
Wiley
Online
2022-09-20
DOI
10.1002/jlb.5mr0822-673r
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting galectin-3 with a high-affinity antibody for inhibition of high-grade serous ovarian cancer and other MUC16/CA-125-expressing malignancies
- (2021) Marina Stasenko et al. Scientific Reports
- Immunoprotective neo-glycoproteins: Chemoenzymatic synthesis of multivalent glycomimetics for inhibition of cancer-related galectin-3
- (2021) Viktoria Heine et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Targeting LAG3/GAL-3 to overcome immunosuppression and enhance anti-tumor immune responses in multiple myeloma
- (2021) Jooeun Bae et al. LEUKEMIA
- Blockade of N-Glycosylation Promotes Antitumor Immune Response of T Cells
- (2020) Shigemi Sasawatari et al. JOURNAL OF IMMUNOLOGY
- Galectin-3 as a Next-Generation Biomarker for Detecting Early Stage of Various Diseases
- (2020) Akira Hara et al. Biomolecules
- Galectin-3 expression and secretion by tumor-associated macrophages in hypoxia promotes breast cancer progression
- (2020) Lei Wang et al. BIOCHEMICAL PHARMACOLOGY
- The promise of Immuno-oncology: implications for defining the value of cancer treatment
- (2019) Howard L. Kaufman et al. Journal for ImmunoTherapy of Cancer
- The expression of galectin-3 in breast cancer and its association with chemoresistance: a systematic review of the literature
- (2019) Ioannis Boutas et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Role and regulation mechanism of Gal-3 in non-small cell lung cancer and its potential clinical therapeutic significance
- (2019) Xiao-Ning Jiang et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Roles of galectin-3 in metabolic disorders and tumor cell metabolism
- (2019) Ying-Shuang Li et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Galectin-3 may serve as a marker for poor prognosis in colorectal cancer: A meta-analysis
- (2019) Chengyan Wang et al. PATHOLOGY RESEARCH AND PRACTICE
- Activation of Galectin-3 (LGALS3) Transcription by Injurious Stimuli in the Liver Is Commonly Mediated by BRG1
- (2019) Zilong Li et al. Frontiers in Cell and Developmental Biology
- Galectin-3: One Molecule for an Alphabet of Diseases, from A to Z
- (2018) Salvatore Sciacchitano et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Myeloid-derived suppressor cells coming of age
- (2018) Filippo Veglia et al. NATURE IMMUNOLOGY
- The Role of Galectins in Cervical Cancer Biology and Progression
- (2018) Lufang Wang et al. Biomed Research International
- Galectin-3 regulation of wound healing and fibrotic processes: insights for chronic skin wound therapeutics
- (2018) Karrington McLeod et al. Journal of Cell Communication and Signaling
- The role of Galectin-3 in modulating tumor growth and immunosuppression within the tumor microenvironment
- (2018) Mohammad Farhad et al. OncoImmunology
- Galectin-3 captures interferon-gamma in the tumor matrix reducing chemokine gradient production and T-cell tumor infiltration
- (2017) Monica Gordon-Alonso et al. Nature Communications
- Galectin-3 acts as an angiogenic switch to induce tumor angiogenesis via Jagged-1/Notch activation
- (2017) Sofia Nascimento dos Santos et al. Oncotarget
- The extracellular matrix in breast cancer
- (2016) Jacob Insua-Rodríguez et al. ADVANCED DRUG DELIVERY REVIEWS
- Multitasking Human Lectin Galectin-3 Interacts with Sulfated Glycosaminoglycans and Chondroitin Sulfate Proteoglycans
- (2016) Melanie L. Talaga et al. BIOCHEMISTRY
- Galectin 3 as a guardian of the tumor microenvironment
- (2016) Peter P. Ruvolo BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Molecular regulation of galectin-3 expression and therapeutic implication in cancer progression
- (2016) Lei Wang et al. BIOMEDICINE & PHARMACOTHERAPY
- Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study
- (2016) Susanna Mandruzzato et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Hepatitis C Virus–Induced Myeloid-Derived Suppressor Cells Suppress NK Cell IFN-γ Production by Altering Cellular Metabolism via Arginase-1
- (2016) Celeste C. Goh et al. JOURNAL OF IMMUNOLOGY
- Galectin signatures contribute to the heterogeneity of breast cancer and provide new prognostic information and therapeutic targets
- (2016) Andrée-Anne Grosset et al. Oncotarget
- Pectic-Oligoshaccharides from Apples Induce Apoptosis and Cell Cycle Arrest in MDA-MB-231 Cells, a Model of Human Breast Cancer
- (2015) Ladan Delphi et al. Asian Pacific Journal of Cancer Prevention
- Short- and Long-term Biologic Variability of Galectin-3 and Other Cardiac Biomarkers in Patients with Stable Heart Failure and Healthy Adults
- (2015) E. I. Schindler et al. CLINICAL CHEMISTRY
- Group 2 Innate Lymphoid Cells Express Functional NKp30 Receptor Inducing Type 2 Cytokine Production
- (2015) Maryam Salimi et al. JOURNAL OF IMMUNOLOGY
- Natural killer (NK) cell profiles in blood and tumour in women with large and locally advanced breast cancer (LLABC) and their contribution to a pathological complete response (PCR) in the tumour following neoadjuvant chemotherapy (NAC): differential restoration of blood profiles by NAC and surgery
- (2015) Chandan Verma et al. Journal of Translational Medicine
- IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis
- (2015) Seth B. Coffelt et al. NATURE
- Galectin-3 Shapes Antitumor Immune Responses by Suppressing CD8+ T Cells via LAG-3 and Inhibiting Expansion of Plasmacytoid Dendritic Cells
- (2015) T. Kouo et al. Cancer Immunology Research
- Higher Incidence of Aggressive Breast Cancers in African-American Women: A Review
- (2015) Gloria J. Morris et al. JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION
- Hypoxia Up-Regulates Galectin-3 in Mammary Tumor Progression and Metastasis
- (2015) Joana T. de Oliveira et al. PLoS One
- Galectin-3 in cancer
- (2014) Lin Song et al. CLINICA CHIMICA ACTA
- Tumor-released Galectin-3, a Soluble Inhibitory Ligand of Human NKp30, Plays an Important Role in Tumor Escape from NK Cell Attack
- (2014) Wei Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Role of Galectin-3 in Leukocyte Recruitment in a Murine Model of Lung Infection by Streptococcus pneumoniae
- (2014) J. Nieminen et al. JOURNAL OF IMMUNOLOGY
- Differential Roles of Galectin-1 and Galectin-3 in Regulating Leukocyte Viability and Cytokine Secretion
- (2014) S. R. Stowell et al. JOURNAL OF IMMUNOLOGY
- Regulation of Alternative Macrophage Activation by Galectin-3
- (2014) A. C. MacKinnon et al. JOURNAL OF IMMUNOLOGY
- Galectin-3 contributes to cisplatin-induced myeloid derived suppressor cells (MDSCs) recruitment in Lewis lung cancer-bearing mice
- (2014) Tian Wang et al. MOLECULAR BIOLOGY REPORTS
- Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer
- (2014) Hao Zhang et al. PLoS One
- Galectin-3 Up-Regulation in Hypoxic and Nutrient Deprived Microenvironments Promotes Cell Survival
- (2014) Rafael Yamashita Ikemori et al. PLoS One
- Sugars boost exhausted tumor-infiltrating lymphocytes by counteracting immunosuppressive activities of galectins
- (2014) Monica Gordon-Alonso et al. OncoImmunology
- Altered Tumor-Cell Glycosylation Promotes Metastasis
- (2014) Irina Häuselmann et al. Frontiers in Oncology
- Galectin-3 Accelerates M2 Macrophage Infiltration and Angiogenesis in Tumors
- (2013) Weizhen Jia et al. AMERICAN JOURNAL OF PATHOLOGY
- Myeloid-derived suppressor cells in breast cancer
- (2013) Joseph Markowitz et al. BREAST CANCER RESEARCH AND TREATMENT
- Oncology Meets Immunology: The Cancer-Immunity Cycle
- (2013) Daniel S. Chen et al. IMMUNITY
- Galectin-3– and phospho-caveolin-1–dependent outside-in integrin signaling mediates the EGF motogenic response in mammary cancer cells
- (2013) Cecile Boscher et al. MOLECULAR BIOLOGY OF THE CELL
- Abstract 2017: Galectin-3 SNP rs10148371 in the anti-death motif NWGR is related to the colon cancer incidence in African Americans
- (2012) Pratima Nangia-Makker et al. CANCER RESEARCH
- Galectin-3 Protein Regulates Mobility of N-cadherin and GM1 Ganglioside at Cell-Cell Junctions of Mammary Carcinoma Cells
- (2012) Cécile Boscher et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Loss of Effector Function of Human Cytolytic T Lymphocytes Is Accompanied by Major Alterations inN- andO-Glycosylation
- (2012) Aristotelis Antonopoulos et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Galectin-3 in preneoplastic lesions of glioma
- (2012) Nguyen Huy Binh et al. JOURNAL OF NEURO-ONCOLOGY
- Clinicopathological significance of decreased galectin-3 expression and the long-term prognosis in patients with breast cancer
- (2012) Sayaka Yamaki et al. SURGERY TODAY
- Breast cancer subtypes express distinct receptor repertoires for tumor-associated macrophage derived cytokines
- (2011) Kelly S. Levano et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Serum Galectin-2, -4, and -8 Are Greatly Increased in Colon and Breast Cancer Patients and Promote Cancer Cell Adhesion to Blood Vascular Endothelium
- (2011) H. Barrow et al. CLINICAL CANCER RESEARCH
- A novel strategy for evasion of NK cell immunity by tumours expressing core2 O-glycans
- (2011) Shigeru Tsuboi et al. EMBO JOURNAL
- Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity
- (2011) Emilie Mamessier et al. JOURNAL OF CLINICAL INVESTIGATION
- Structure of the human activating natural cytotoxicity receptor NKp30 bound to its tumor cell ligand B7-H6
- (2011) Yili Li et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Galectin-3 Enhances Proliferation and Angiogenesis of Endothelial Cells Differentiated from Bone Marrow Mesenchymal Stem Cells
- (2011) S.Y. Wan et al. TRANSPLANTATION PROCEEDINGS
- Diagnostic Utility of Galectin-3 in Thyroid Cancer
- (2010) Connie G. Chiu et al. AMERICAN JOURNAL OF PATHOLOGY
- Galectin 3 aggravates joint inflammation and destruction in antigen-induced arthritis
- (2010) Huamei Forsman et al. ARTHRITIS AND RHEUMATISM
- A Galectin-3 Ligand Corrects the Impaired Function of Human CD4 and CD8 Tumor-Infiltrating Lymphocytes and Favors Tumor Rejection in Mice
- (2010) N. Demotte et al. CANCER RESEARCH
- Clinicopathlogic and Immunohistochemical Characteristics of Triple Negative Invasive Lobular Carcinoma
- (2010) Ja Seung Koo et al. YONSEI MEDICAL JOURNAL
- Galectin 3 induces a distinctive pattern of cytokine and chemokine production in rheumatoid synovial fibroblasts via selective signaling pathways
- (2009) Andrew Filer et al. ARTHRITIS AND RHEUMATISM
- Population Differences in Breast Cancer: Survey in Indigenous African Women Reveals Over-Representation of Triple-Negative Breast Cancer
- (2009) Dezheng Huo et al. JOURNAL OF CLINICAL ONCOLOGY
- A primate subfamily of galectins expressed at the maternal-fetal interface that promote immune cell death
- (2009) N. G. Than et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Galectin-3 negatively regulates TCR-mediated CD4+ T-cell activation at the immunological synapse
- (2009) H.-Y. Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Racial Disparity in Breast Cancer and Functional Germ Line Mutation in Galectin-3 (rs4644): A Pilot Study
- (2008) V. Balan et al. CANCER RESEARCH
- Modified citrus pectin anti-metastatic properties: one bullet, multiple targets
- (2008) Vladislav V. Glinsky et al. CARBOHYDRATE RESEARCH
- Restoring the Association of the T Cell Receptor with CD8 Reverses Anergy in Human Tumor-Infiltrating Lymphocytes
- (2008) Nathalie Demotte et al. IMMUNITY
- Macrophages define the invasive microenvironment in breast cancer
- (2008) Jeffrey W. Pollard JOURNAL OF LEUKOCYTE BIOLOGY
- Stromal gene expression predicts clinical outcome in breast cancer
- (2008) Greg Finak et al. NATURE MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started